• Home
  • Pharmaceuticals and Healthcare
Glycogen Synthase Kinase 3 Beta Market, Global Outlook and Forecast 2022-2028

Glycogen Synthase Kinase 3 Beta Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281360 | No. of Pages: 77 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022 
This report contains market size and forecasts of Glycogen Synthase Kinase 3 Beta in global, including the following market information:
Global Glycogen Synthase Kinase 3 Beta Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glycogen Synthase Kinase 3 Beta Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Glycogen Synthase Kinase 3 Beta companies in 2021 (%)
The global Glycogen Synthase Kinase 3 Beta market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
AP-001 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glycogen Synthase Kinase 3 Beta include Mitsubishi Tanabe Pharma Corp, Neurim Pharmaceuticals Ltd, Actuate Therapeutics Inc, DiaMedica Therapeutics Inc, Angelini Group, Jeil Pharmaceutical Co Ltd and AMO Pharma Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glycogen Synthase Kinase 3 Beta manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glycogen Synthase Kinase 3 Beta Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glycogen Synthase Kinase 3 Beta Market Segment Percentages, by Type, 2021 (%)
    AP-001
    AP-1
    DM-204
    Neu-120
    Others
Global Glycogen Synthase Kinase 3 Beta Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glycogen Synthase Kinase 3 Beta Market Segment Percentages, by Application, 2021 (%)
    Musculoskeletal Disorder
    Lung Cancer
    Dyskinesia
    Menkes Disease
    Others
Global Glycogen Synthase Kinase 3 Beta Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Glycogen Synthase Kinase 3 Beta Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glycogen Synthase Kinase 3 Beta revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glycogen Synthase Kinase 3 Beta revenues share in global market, 2021 (%)
Key companies Glycogen Synthase Kinase 3 Beta sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Glycogen Synthase Kinase 3 Beta sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Mitsubishi Tanabe Pharma Corp
    Neurim Pharmaceuticals Ltd
    Actuate Therapeutics Inc
    DiaMedica Therapeutics Inc
    Angelini Group
    Jeil Pharmaceutical Co Ltd
    AMO Pharma Ltd
1 Introduction to Research & Analysis Reports
    1.1 Glycogen Synthase Kinase 3 Beta Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Glycogen Synthase Kinase 3 Beta Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Glycogen Synthase Kinase 3 Beta Overall Market Size
    2.1 Global Glycogen Synthase Kinase 3 Beta Market Size: 2021 VS 2028
    2.2 Global Glycogen Synthase Kinase 3 Beta Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Glycogen Synthase Kinase 3 Beta Sales: 2017-2028
3 Company Landscape
    3.1 Top Glycogen Synthase Kinase 3 Beta Players in Global Market
    3.2 Top Global Glycogen Synthase Kinase 3 Beta Companies Ranked by Revenue
    3.3 Global Glycogen Synthase Kinase 3 Beta Revenue by Companies
    3.4 Global Glycogen Synthase Kinase 3 Beta Sales by Companies
    3.5 Global Glycogen Synthase Kinase 3 Beta Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Glycogen Synthase Kinase 3 Beta Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Glycogen Synthase Kinase 3 Beta Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Glycogen Synthase Kinase 3 Beta Players in Global Market
        3.8.1 List of Global Tier 1 Glycogen Synthase Kinase 3 Beta Companies
        3.8.2 List of Global Tier 2 and Tier 3 Glycogen Synthase Kinase 3 Beta Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Glycogen Synthase Kinase 3 Beta Market Size Markets, 2021 & 2028
        4.1.2 AP-001
        4.1.3 AP-1
        4.1.4 DM-204
        4.1.5 Neu-120
        4.1.6 Others
    4.2 By Type - Global Glycogen Synthase Kinase 3 Beta Revenue & Forecasts
        4.2.1 By Type - Global Glycogen Synthase Kinase 3 Beta Revenue, 2017-2022
        4.2.2 By Type - Global Glycogen Synthase Kinase 3 Beta Revenue, 2023-2028
        4.2.3 By Type - Global Glycogen Synthase Kinase 3 Beta Revenue Market Share, 2017-2028
    4.3 By Type - Global Glycogen Synthase Kinase 3 Beta Sales & Forecasts
        4.3.1 By Type - Global Glycogen Synthase Kinase 3 Beta Sales, 2017-2022
        4.3.2 By Type - Global Glycogen Synthase Kinase 3 Beta Sales, 2023-2028
        4.3.3 By Type - Global Glycogen Synthase Kinase 3 Beta Sales Market Share, 2017-2028
    4.4 By Type - Global Glycogen Synthase Kinase 3 Beta Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Glycogen Synthase Kinase 3 Beta Market Size, 2021 & 2028
        5.1.2 Musculoskeletal Disorder
        5.1.3 Lung Cancer
        5.1.4 Dyskinesia
        5.1.5 Menkes Disease
        5.1.6 Others
    5.2 By Application - Global Glycogen Synthase Kinase 3 Beta Revenue & Forecasts
        5.2.1 By Application - Global Glycogen Synthase Kinase 3 Beta Revenue, 2017-2022
        5.2.2 By Application - Global Glycogen Synthase Kinase 3 Beta Revenue, 2023-2028
        5.2.3 By Application - Global Glycogen Synthase Kinase 3 Beta Revenue Market Share, 2017-2028
    5.3 By Application - Global Glycogen Synthase Kinase 3 Beta Sales & Forecasts
        5.3.1 By Application - Global Glycogen Synthase Kinase 3 Beta Sales, 2017-2022
        5.3.2 By Application - Global Glycogen Synthase Kinase 3 Beta Sales, 2023-2028
        5.3.3 By Application - Global Glycogen Synthase Kinase 3 Beta Sales Market Share, 2017-2028
    5.4 By Application - Global Glycogen Synthase Kinase 3 Beta Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Glycogen Synthase Kinase 3 Beta Market Size, 2021 & 2028
    6.2 By Region - Global Glycogen Synthase Kinase 3 Beta Revenue & Forecasts
        6.2.1 By Region - Global Glycogen Synthase Kinase 3 Beta Revenue, 2017-2022
        6.2.2 By Region - Global Glycogen Synthase Kinase 3 Beta Revenue, 2023-2028
        6.2.3 By Region - Global Glycogen Synthase Kinase 3 Beta Revenue Market Share, 2017-2028
    6.3 By Region - Global Glycogen Synthase Kinase 3 Beta Sales & Forecasts
        6.3.1 By Region - Global Glycogen Synthase Kinase 3 Beta Sales, 2017-2022
        6.3.2 By Region - Global Glycogen Synthase Kinase 3 Beta Sales, 2023-2028
        6.3.3 By Region - Global Glycogen Synthase Kinase 3 Beta Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Glycogen Synthase Kinase 3 Beta Revenue, 2017-2028
        6.4.2 By Country - North America Glycogen Synthase Kinase 3 Beta Sales, 2017-2028
        6.4.3 US Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.4.4 Canada Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.4.5 Mexico Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Glycogen Synthase Kinase 3 Beta Revenue, 2017-2028
        6.5.2 By Country - Europe Glycogen Synthase Kinase 3 Beta Sales, 2017-2028
        6.5.3 Germany Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.5.4 France Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.5.5 U.K. Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.5.6 Italy Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.5.7 Russia Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.5.8 Nordic Countries Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.5.9 Benelux Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Glycogen Synthase Kinase 3 Beta Revenue, 2017-2028
        6.6.2 By Region - Asia Glycogen Synthase Kinase 3 Beta Sales, 2017-2028
        6.6.3 China Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.6.4 Japan Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.6.5 South Korea Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.6.6 Southeast Asia Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.6.7 India Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Glycogen Synthase Kinase 3 Beta Revenue, 2017-2028
        6.7.2 By Country - South America Glycogen Synthase Kinase 3 Beta Sales, 2017-2028
        6.7.3 Brazil Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.7.4 Argentina Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Glycogen Synthase Kinase 3 Beta Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Glycogen Synthase Kinase 3 Beta Sales, 2017-2028
        6.8.3 Turkey Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.8.4 Israel Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.8.5 Saudi Arabia Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
        6.8.6 UAE Glycogen Synthase Kinase 3 Beta Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Mitsubishi Tanabe Pharma Corp
        7.1.1 Mitsubishi Tanabe Pharma Corp Corporate Summary
        7.1.2 Mitsubishi Tanabe Pharma Corp Business Overview
        7.1.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.1.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.1.5 Mitsubishi Tanabe Pharma Corp Key News
    7.2 Neurim Pharmaceuticals Ltd
        7.2.1 Neurim Pharmaceuticals Ltd Corporate Summary
        7.2.2 Neurim Pharmaceuticals Ltd Business Overview
        7.2.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.2.4 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.2.5 Neurim Pharmaceuticals Ltd Key News
    7.3 Actuate Therapeutics Inc
        7.3.1 Actuate Therapeutics Inc Corporate Summary
        7.3.2 Actuate Therapeutics Inc Business Overview
        7.3.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.3.4 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.3.5 Actuate Therapeutics Inc Key News
    7.4 DiaMedica Therapeutics Inc
        7.4.1 DiaMedica Therapeutics Inc Corporate Summary
        7.4.2 DiaMedica Therapeutics Inc Business Overview
        7.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.4.4 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.4.5 DiaMedica Therapeutics Inc Key News
    7.5 Angelini Group
        7.5.1 Angelini Group Corporate Summary
        7.5.2 Angelini Group Business Overview
        7.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.5.4 Angelini Group Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.5.5 Angelini Group Key News
    7.6 Jeil Pharmaceutical Co Ltd
        7.6.1 Jeil Pharmaceutical Co Ltd Corporate Summary
        7.6.2 Jeil Pharmaceutical Co Ltd Business Overview
        7.6.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.6.4 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.6.5 Jeil Pharmaceutical Co Ltd Key News
    7.7 AMO Pharma Ltd
        7.7.1 AMO Pharma Ltd Corporate Summary
        7.7.2 AMO Pharma Ltd Business Overview
        7.7.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Major Product Offerings
        7.7.4 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales and Revenue in Global (2017-2022)
        7.7.5 AMO Pharma Ltd Key News
8 Global Glycogen Synthase Kinase 3 Beta Production Capacity, Analysis
    8.1 Global Glycogen Synthase Kinase 3 Beta Production Capacity, 2017-2028
    8.2 Glycogen Synthase Kinase 3 Beta Production Capacity of Key Manufacturers in Global Market
    8.3 Global Glycogen Synthase Kinase 3 Beta Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Glycogen Synthase Kinase 3 Beta Supply Chain Analysis
    10.1 Glycogen Synthase Kinase 3 Beta Industry Value Chain
    10.2 Glycogen Synthase Kinase 3 Beta Upstream Market
    10.3 Glycogen Synthase Kinase 3 Beta Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Glycogen Synthase Kinase 3 Beta Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com